Stocks and Investing Stocks and Investing
Wed, January 4, 2017
Tue, January 3, 2017
Fri, December 30, 2016
Thu, December 29, 2016
Wed, December 28, 2016
Tue, December 27, 2016
Mon, December 26, 2016
Fri, December 23, 2016
Thu, December 22, 2016

Anupam Rama Initiated (SRPT) at Buy and Held Target at $40 on, Dec 22nd, 2016


Published on 2024-10-25 19:46:30 - WOPRAI, Anupam Rama
  Print publication without navigation


Anupam Rama of JP Morgan, Initiated "Sarepta Therapeutics, Inc." (SRPT) at Buy and Held Target at $40 on, Dec 22nd, 2016.

Anupam has made no other calls on SRPT in the last 4 months.



There are 5 other peers that have a rating on SRPT. Out of the 5 peers that are also analyzing SRPT, 2 agree with Anupam's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Matthew Harrison of "Morgan Stanley" Initiated at Hold on, Thursday, October 27th, 2016
  • Mike Guo of "SunTrust Robinson Humphrey" Upgraded from Sell to Hold on, Monday, September 19th, 2016


These are the ratings of the 3 analyists that currently disagree with Anupam


  • Alethia Young of "Credit Suisse" Initiated at Buy on, Tuesday, October 18th, 2016
  • Brian Abrahams of "RBC Capital" Maintained at Buy with Increased Target to $108 on, Wednesday, September 28th, 2016
  • Yun Zhong of "Janney Montgomery Scott" Upgraded from Hold to Strong Buy on, Monday, September 19th, 2016